Crohn’s disease (also: regional enteritis) and ulcerative colitis area chronic, inflammatory conditions of the gastrointestinal tract. Although the inflammation of the mucosa is usually episodic in nature, these Inflammatory bowel diseases (IBD) are associated with an increased risk of developing colorectal cancer. Inflammatory bowel disease well-managed patients suffering from IBD have an approximately two times higher chance for contracting CRC as the population at large.
Inflammatory bowel disease (IBD) patients, which include the two related conditions of Crohn’s disease and ulcerative colitis, have an increased risk of developing colorectal cancer (CRC) (Itzkowitz and Yio 2004). For patients with Crohn’s disease [CD], the excess risk for contracting CRC has been estimated at 1.9, whereas the risk for small bowel cancer is 27.1...
KeywordsInflammatory Bowel Disease Ulcerative Colitis Familial Adenomatous Polyposis Primary Sclerosing Cholangitis Sclerosing Cholangitis
- Baan B, Dihal AA, Hoff E, Bos CL, Voorneveld PW, Koelink PJ, Wildenberg ME, Muncan V, Heijmans J, Verspaget HW, Richel DJ, Hardwick JC, Hommes DW, Peppelenbosch MP, van den Brink GR (2012) 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer. Gut 61(12):1708–1715CrossRefPubMedGoogle Scholar
- Pinczowski D1, Ekbom A, Baron J, Yuen J, Adami HO (1994) Risk factors for colorectal cancer in patients with ulcerative colitis: a case–control study. Gastroenterology 107(1):117–20Google Scholar
- Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR (2013) Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case–control study. Clin Gastroenterol Hepatol 11(12):1601–8.e1–1601–8.e4CrossRefGoogle Scholar